Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04472338 · ClinicalTrials.gov registry record
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
A clinical trial of Prostate Carcinoma, sponsored by University of Washington.
- Recruiting
- Registry status
- 450
- Enrollment target
- 8
- Study locations
NCT04472338 is a study of Prostate Carcinoma that is actively recruiting participants, run by University of Washington. The registered enrollment target is 450 participants, below the 1,494-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (70% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT04472338, a study of Prostate Carcinoma, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help identify ways to detect cancer earlier, thereby improving treatment and methods of early detection in the future.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Study Locations (8)
California
- City of Hope - Duarte
- University of California, San Francisco - San Francisco
Illinois
- Northwestern - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Oregon
- OHSU Knight Cancer Institute - Portland
Pennsylvania
- University of Pennsylvania/Abramson Cancer Center - Philadelphia
Texas
- University of Texas Health Science Center at San Antonio - San Antonio
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2020-05-21 |
| Est. Completion | 2030-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04472338
The ClinicalTrials.gov registry entry for NCT04472338 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,494-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (70% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT04472338 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04472338 about?
NCT04472338 is a clinical study titled "Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study". This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help iden...
What is the current status of trial NCT04472338?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2020-05-21. Estimated completion is 2030-08-31.
What conditions does trial NCT04472338 study?
This clinical trial studies the following conditions: Prostate Carcinoma.
What interventions are being tested in trial NCT04472338?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04472338?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04472338 being conducted?
This trial has 8 study locations across California, Illinois, Massachusetts, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
RECRUITING · NA
-
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
RECRUITING · Early Phase 1
-
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
RECRUITING
-
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
RECRUITING · Phase 2
-
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
RECRUITING · Early Phase 1
-
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.